It might have been SARS- or war-related travel fear, an over-abundance of proteomics conferences, the general economic climate, or a combination of all the above: Cambridge Healthtech Institute’s “Proteins to Profits” conference in Munich last month was a far cry from the previous year’s meeting, judged by the sparse attendance and by the rather downbeat mood.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.